Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model

[1]  Shuyue Wang,et al.  Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters , 2021, Frontiers in Immunology.

[2]  Binbin Chen,et al.  Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer , 2021, Stem cell reports.

[3]  P. Symonds,et al.  Cancer Vaccines, Adjuvants, and Delivery Systems , 2021, Frontiers in Immunology.

[4]  M. Zöller,et al.  Dendritic cells loaded with exosomes derived from cancer stem cell‐enriched spheroids as a potential immunotherapeutic option , 2021, Journal of cellular and molecular medicine.

[5]  Feridoun Karimi-Busheri,et al.  Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines , 2021, Cancer cell international.

[6]  L. Eini,et al.  Primary colonospheres maintain stem cell‐like key features after cryopreservation , 2020, Journal of cellular physiology.

[7]  H. Abdollahi,et al.  Cancer stem cells: A review from origin to therapeutic implications , 2020, Journal of cellular physiology.

[8]  L. Conti,et al.  Breast cancer stem cell antigens as targets for immunotherapy. , 2020, Seminars in immunology.

[9]  L. Qin,et al.  Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment , 2019, Front. Oncol..

[10]  J. D'haese,et al.  Advances in cancer immunotherapy 2019 – latest trends , 2019, Journal of experimental & clinical cancer research : CR.

[11]  J. Berzofsky,et al.  Strategies for developing and optimizing cancer vaccines , 2019, F1000Research.

[12]  Masahiro Shibata,et al.  Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer , 2019, Cancers.

[13]  S. Yoo,et al.  Recent Advances in Cancer Stem Cell-Targeted Immunotherapy , 2019, Cancers.

[14]  Wei-Chung Cheng,et al.  Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer , 2019, Journal of Hematology & Oncology.

[15]  D M Parkin,et al.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.

[16]  D. Mukherji,et al.  Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells , 2018, Front. Oncol..

[17]  G. Donofrio,et al.  Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter , 2018, Cancer Immunology, Immunotherapy.

[18]  F. Sotgia,et al.  Cancer stem cells (CSCs): metabolic strategies for their identification and eradication , 2018, The Biochemical journal.

[19]  Hongming Zhang,et al.  Current status and future directions of cancer immunotherapy , 2018, Journal of Cancer.

[20]  A. Zarnani,et al.  Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma , 2018, International journal of cancer.

[21]  O. Finn.  The dawn of vaccines for cancer prevention , 2017, Nature Reviews Immunology.

[22]  J. Medema,et al.  Intra-tumor heterogeneity from a cancer stem cell perspective , 2017, Molecular Cancer.

[23]  R. May,et al.  Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells , 2017, Molecular Cancer.

[24]  Yuhong Bian,et al.  Isolation of colorectal cancer stem-like cells , 2016, Cytotechnology.

[25]  B. Vu,et al.  Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results , 2016, OncoTargets and therapy.

[26]  G. Devi,et al.  Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. , 2016, Pharmacology & therapeutics.

[27]  Marzieh Ebrahimi,et al.  Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses. , 2016, Cancer letters.

[28]  S. Yoo,et al.  A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer , 2016, Oncotarget.

[29]  W. Oyen,et al.  Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity , 2016, Cancer Immunology, Immunotherapy.

[30]  Xin-hua Liang,et al.  Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma , 2016, OncoTargets and therapy.

[31]  J. Dou,et al.  Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine , 2015, Journal of Ovarian Research.

[32]  H. Takaku,et al.  A tumor lysate is an effective vaccine antigen for the stimulation of CD4+ T-cell function and subsequent induction of antitumor immunity mediated by CD8+ T cells , 2015, Cancer biology & therapy.

[33]  A. Chang,et al.  Concise Reviews : Targeting Cancer Stem Cells Using Immunologic Approaches , 2015 .

[34]  Qiao Li,et al.  Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine , 2015, Journal of Cancer Research and Clinical Oncology.

[35]  Qiao Li,et al.  Safety and efficacy study of lung cancer stem cell vaccine , 2015, Immunologic Research.

[36]  S. Said-Fernández,et al.  Understanding the colon cancer stem cells and perspectives on treatment , 2015, Cancer Cell International.

[37]  A. Chang,et al.  Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells , 2015, Oncoimmunology.

[38]  F. Osorio,et al.  Tumor cell lysates as immunogenic sources for cancer vaccine design , 2014, Human vaccines & immunotherapeutics.

[39]  Fang Xie,et al.  B16 cell lysates plus polyinosinic-cytidylic acid effectively eradicate melanoma in a mouse model by acting as a prophylactic vaccine. , 2014, Molecular medicine reports.

[40]  A. Saftoiu,et al.  Stem Cells, Colorectal Cancer and Cancer Stem Cell Markers Correlations , 2014, Current health sciences journal.

[41]  Manuel Hidalgo,et al.  Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.

[42]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[43]  C. June,et al.  Radiation and immunotherapy: a synergistic combination. , 2013, The Journal of clinical investigation.

[44]  Yu Zhang,et al.  Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver , 2013, Clinical & Experimental Metastasis.

[45]  H. Ishii,et al.  Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. , 2013, International journal of oncology.

[46]  A. Loubat,et al.  Preventive Cancer Stem Cell‐Based Vaccination Reduces Liver Metastasis Development in a Rat Colon Carcinoma Syngeneic Model , 2013, Stem cells.

[47]  Rosanna La Rocca,et al.  Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules , 2013, The Journal of Immunology.

[48]  Shanrong Liu,et al.  Pluripotency transcription factors and cancer stem cells: small genes make a big difference , 2013, Chinese journal of cancer.

[49]  R. Schoen,et al.  MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study , 2012, Cancer Prevention Research.

[50]  A. Chang,et al.  Targeting cancer stem cells via dendritic-cell vaccination , 2012, Oncoimmunology.

[51]  M. Biffoni,et al.  Proliferation State and Polo‐Like Kinase1 Dependence of Tumorigenic Colon Cancer Cells , 2012, Stem cells.

[52]  H. Ren,et al.  Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells , 2012, Molecular and Cellular Biochemistry.

[53]  A. Chang,et al.  Cancer stem cell vaccination confers significant antitumor immunity. , 2012, Cancer research.

[54]  C. Caldas,et al.  Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance , 2011, Breast Cancer Research.

[55]  Michael Kahn,et al.  Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells? , 2010, Clinical Cancer Research.

[56]  Mette Jensen,et al.  Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper , 2008, BMC Medical Imaging.

[57]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[58]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[59]  A. Kaufmann,et al.  Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines , 2012, Journal of Cancer Research and Clinical Oncology.

[60]  Pang-Kuo Lo,et al.  The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres , 2011 .

[61]  R. Bjerkvig,et al.  Expression of extracellular matrix components in a highly infiltrative in vivo glioma model , 2002, Acta Neuropathologica.